Sarah Cannon Research Institute at Mary Crowley — Dallas, Texas

Sarah Cannon Research Institute at Mary Crowley is a clinical research site located in Dallas, Texas, United States 75230.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute at Mary Crowley has participated in 8 clinical trials with 8 currently active.

Therapeutic areas: Solid Tumors, KRAS Mutation, Solid Tumor, Non-Small Cell Lung Cancer.

Sponsors: Boehringer Ingelheim, Inhibrx Biosciences, Inc, Revolution Medicines, Inc..

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute at Mary Crowley?

Sarah Cannon Research Institute at Mary Crowley has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute at Mary Crowley conducted?

Sarah Cannon Research Institute at Mary Crowley has 8 clinical trials on record, with 8 currently active. Their work covers Solid Tumors, KRAS Mutation, Solid Tumor, Non-Small Cell Lung Cancer.

Is Sarah Cannon Research Institute at Mary Crowley accredited by Crixeo Health?

Yes — Sarah Cannon Research Institute at Mary Crowley holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Sarah Cannon Research Institute at Mary Crowley?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.